There are 3163 resources available
278P - Prognostic and biologic significance of HER2-low early-stage breast cancer with long-term follow-up
Presenter: Yuka Niwa
Session: Poster session 14
280P - Personalized treatment approaches with HER2DX in early HER2-positive breast cancer: A precision tool for treatment decision-making
Presenter: Marta Tapia Céspedes
Session: Poster session 14
281P - Prevalence of HER2-low breast cancer in the GEICAM/2011-06 trial: Agreement in HER2-low classification between standardized immunohistochemistry assays
Presenter: Federico Rojo
Session: Poster session 14
282P - Impact of pembrolizumab on ovarian function in young triple negative breast cancer patients treated with chemo-immunotherapy
Presenter: Anne Perdrix
Session: Poster session 14
283P - Immune-mediated secondary adrenal insufficiency is more commonly found in younger patients undergoing neoadjuvant treatment for early breast cancer
Presenter: Laura Lapuchesky
Session: Poster session 14
284P - Clinical and molecular characteristics of early-stage triple-negative breast cancer (eTNBC) patients with germline pathogenic variants in homologous recombination repair genes
Presenter: Adela Rodriguez Hernandez
Session: Poster session 14
285P - Adherence to endocrine therapy and sexual dysfunction in patients older than 65 years with early estrogen receptor-positive breast cancer
Presenter: Daniele Assad
Session: Poster session 14
286P - Impact of adjuvant endocrine therapy on survival outcomes in female breast cancer patients over 50
Presenter: Hanxiao Zuo
Session: Poster session 14
287P - Cognitive impairment in older breast cancer survivors
Presenter: Sharon Giordano
Session: Poster session 14